Global CRISPR Research Report 2023: The Future of Revolutionary Gene Editing Technology - Changing the Landscape of Healthcare and Biotechnology
August 03, 2023 05:13 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CRISPR Market by Product (Enzymes, Kits, Libraries), Services (gRNA Design, Cell Line Engineering, Screening), Application (Drug Discovery &...
$12.56Bn Growth for Cell Therapy Market to Hit 7.2% CAGR Propelled by Autologous Segment During 2020-2027 | Report by The Insight Partners
July 18, 2023 08:05 ET
|
The Insight Partners
Pune, India, July 18, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Cell Therapy Market Size Report, Share, Trends & Forecast to 2027 - COVID-19...
18.4% CAGR for Genome Editing Market Worth $16.98 Billion, Globally, by 2028 Lead by CRISPR Segment During 2021-2028 | The Insight Partners
June 23, 2023 14:02 ET
|
The Insight Partners
Pune, India, June 23, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Genome Editing Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology,...
Global Epigenetic Therapeutics Market to Reach $9.8 Billion by 2028 - Projected Revenue Shares for PRAP, Kinase, IDH, HDAC, DNMT, and KMT Inhibitors
June 23, 2023 05:08 ET
|
Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Epigenetic Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global epigenetic therapeutics market was...
Global Allogeneic Cell Therapy Market to 2030: Increasing FDA Approvals of Allogeneic Cell Therapies Drives Growth
May 31, 2023 08:43 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Allogeneic Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Stem Cell, Non-stem Cell), By Therapeutic Area (Hematological...
Global Genome Editing/Genome Engineering Market Report 2023: Rising Prevalence of Cancer and Other Genetic Disorders Fuels the Sector
May 30, 2023 07:58 ET
|
Research and Markets
Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Genome Editing/Genome Engineering Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Gene Editing Technologies Market Report 2023: Sector is Expected to Reach $16.37 Billion by 2032 at a CAGR of 27.5%
May 30, 2023 06:08 ET
|
Research and Markets
Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Gene Editing Technologies Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and...
Gene Editing Global Market Report 2023: Rising Infectious Diseases Fuel the Sector
May 12, 2023 10:03 ET
|
Research and Markets
Dublin, May 12, 2023 (GLOBE NEWSWIRE) -- The "Gene Editing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 04, 2023 07:30 ET
|
Intellia Therapeutics, Inc.
Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to submit...
Macomics Presents its ENIGMAC™ Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR
April 17, 2023 13:30 ET
|
Macomics Limited
EDINBURGH, United Kingdom and CAMBRIDGE, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery has presented data demonstrating the power of its...